Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.730
+0.410 (12.35%)
At close: Nov 4, 2024, 4:00 PM
3.720
-0.010 (-0.27%)
After-hours: Nov 4, 2024, 4:19 PM EST
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 124 employees as of December 31, 2023. The number of employees decreased by 32 or -20.51% compared to the previous year.
Employees
124
Change (1Y)
-32
Growth (1Y)
-20.51%
Revenue / Employee
$327,097
Profits / Employee
-$1,569,790
Market Cap
265.23M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 124 | -32 | -20.51% |
Dec 31, 2022 | 156 | -21 | -11.86% |
Dec 31, 2021 | 177 | 53 | 42.74% |
Dec 31, 2020 | 124 | 62 | 100.00% |
Dec 31, 2019 | 62 | - | - |
Related Stocks
Company Name | Employees |
---|---|
High Tide | 1,550 |
SOPHiA GENETICS | 430 |
Poseida Therapeutics | 330 |
Amarin Corporation | 275 |
Editas Medicine | 265 |
Precigen | 202 |
Omeros | 198 |
Enanta Pharmaceuticals | 145 |
ZNTL News
- 3 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc - GuruFocus
- 6 weeks ago - Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm - PRNewsWire
- 7 weeks ago - FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers - Benzinga
- 7 weeks ago - Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024 - GlobeNewsWire
- 2 months ago - Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL - Business Wire
- 2 months ago - Investors In Zentalis Pharmaceuticals Inc Encouraged To Participate In Fraud Investigation With The Schall Law Firm - Accesswire